XML 68 R56.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Acquisitions - Estimated Useful Life and Fair Value (Detail) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2021 USD ($)
BioFlex And NTM Acquisition |
Fair Value | $ 17,150
BioFlex And NTM Acquisition | Customer Relationships [Member] |
Weighted Average Useful Life (in years) | 10 years
Fair Value | $ 13,240
BioFlex And NTM Acquisition | Developed Technology Rights [Member] |
Weighted Average Useful Life (in years) | 11 years
Fair Value | $ 3,540
BioFlex And NTM Acquisition | Trademark and tradename [Member] |
Weighted Average Useful Life (in years) | 15 years
Fair Value | $ 310
BioFlex And NTM Acquisition | Noncompete Agreements [Member] |
Weighted Average Useful Life (in years) | 3 years
Fair Value | $ 60
Avitide Inc. |
Fair Value | $ 46,650
Avitide Inc. | Customer Relationships [Member] |
Weighted Average Useful Life (in years) | 13 years
Fair Value | $ 24,580
Avitide Inc. | Developed Technology Rights [Member] |
Weighted Average Useful Life (in years) | 15 years
Fair Value | $ 20,650
Avitide Inc. | Trademark and tradename [Member] |
Weighted Average Useful Life (in years) | 18 years
Fair Value | $ 1,210
Avitide Inc. | Noncompete Agreements [Member] |
Weighted Average Useful Life (in years) | 3 years
Fair Value | $ 210
Polymem S.A. |
Fair Value | $ 9,096
Polymem S.A. | Developed Technology Rights [Member] |
Weighted Average Useful Life (in years) | 13 years
Fair Value | $ 8,274
Polymem S.A. | Trademark and tradename [Member] |
Weighted Average Useful Life (in years) | 14 years
Fair Value | $ 510
Polymem S.A. | Noncompete Agreements [Member] |
Weighted Average Useful Life (in years) | 5 years
Fair Value | $ 312
ARTeSYN Biosolutions |
Fair Value | $ 67,390
ARTeSYN Biosolutions | Customer Relationships [Member] |
Weighted Average Useful Life (in years) | 17 years
Fair Value | $ 38,400
ARTeSYN Biosolutions | Developed Technology Rights [Member] |
Weighted Average Useful Life (in years) | 15 years
Fair Value | $ 27,060
ARTeSYN Biosolutions | Trademark and tradename [Member] |
Weighted Average Useful Life (in years) | 21 years
Fair Value | $ 1,630
ARTeSYN Biosolutions | Noncompete Agreements [Member] |
Weighted Average Useful Life (in years) | 3 years
Fair Value | $ 300
Non Metallic Solutions |
Fair Value | $ 8,460
Non Metallic Solutions | Customer Relationships [Member] |
Weighted Average Useful Life (in years) | 14 years
Fair Value | $ 6,370
Non Metallic Solutions | Developed Technology Rights [Member] |
Weighted Average Useful Life (in years) | 12 years
Fair Value | $ 1,810
Non Metallic Solutions | Trademark and tradename [Member] |
Weighted Average Useful Life (in years) | 15 years
Fair Value | $ 190
Non Metallic Solutions | Noncompete Agreements [Member] |
Weighted Average Useful Life (in years) | 3 years
Fair Value | $ 90

X
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 + Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -URI http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=rgen_BioflexAndNtmAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=rgen_AvitideIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=rgen_PolymemSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=rgen_ArtesynBiosolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=rgen_NonMetallicSolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |